Vor Operating Income from 2010 to 2025

VOR Stock  USD 0.88  0.01  1.66%   
Vor Biopharma Operating Income yearly trend continues to be relatively stable with very little volatility. Operating Income is likely to grow to about -115.1 M this year. Operating Income is earnings before interest and taxes (EBIT), representing the amount of profit Vor Biopharma generates from its operations. View All Fundamentals
 
Operating Income  
First Reported
2019-12-31
Previous Quarter
-28.5 M
Current Value
-31.3 M
Quarterly Volatility
9.1 M
 
Covid
Check Vor Biopharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Vor Biopharma's main balance sheet or income statement drivers, such as Net Interest Income of 4.5 M, Interest Income of 4.5 M or Depreciation And Amortization of 3.4 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.75. Vor financial statements analysis is a perfect complement when working with Vor Biopharma Valuation or Volatility modules.
  
Check out the analysis of Vor Biopharma Correlation against competitors.
To learn how to invest in Vor Stock, please use our How to Invest in Vor Biopharma guide.

Latest Vor Biopharma's Operating Income Growth Pattern

Below is the plot of the Operating Income of Vor Biopharma over the last few years. Operating Income is the amount of profit realized from Vor Biopharma operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Vor Biopharma is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. It is earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations. Vor Biopharma's Operating Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Vor Biopharma's overall financial position and show how it may be relating to other accounts over time.
Operating Income10 Years Trend
Slightly volatile
   Operating Income   
       Timeline  

Vor Operating Income Regression Statistics

Arithmetic Mean(37,769,109)
Geometric Mean11,247,175
Coefficient Of Variation(130.70)
Mean Deviation42,691,762
Median(2,860,000)
Standard Deviation49,365,219
Sample Variance2436.9T
Range123.2M
R-Value(0.86)
Mean Square Error669.2T
R-Squared0.74
Significance0.000017
Slope(8,941,877)
Total Sum of Squares36553.9T

Vor Operating Income History

2025-115.1 M
2024-121.2 M
2023-126 M
2022-93.4 M
2021-69 M
2020-43.4 M
2019-10.4 M

Other Fundumenentals of Vor Biopharma

Vor Biopharma Operating Income component correlations

1.00.870.79-0.66-0.720.760.890.94-0.280.99-0.020.990.230.690.730.68
1.00.850.77-0.68-0.670.750.850.95-0.251.0-0.041.00.230.650.680.63
0.870.850.69-0.61-0.930.570.870.87-0.620.84-0.30.830.320.550.910.86
0.790.770.69-0.66-0.720.890.790.61-0.340.760.350.75-0.330.820.710.66
-0.66-0.68-0.61-0.660.51-0.72-0.5-0.590.42-0.7-0.13-0.70.16-0.51-0.51-0.31
-0.72-0.67-0.93-0.720.51-0.61-0.87-0.640.75-0.670.11-0.64-0.14-0.66-0.95-0.93
0.760.750.570.89-0.72-0.610.770.52-0.350.740.570.74-0.260.920.580.52
0.890.850.870.79-0.5-0.870.770.77-0.40.840.080.820.190.840.880.88
0.940.950.870.61-0.59-0.640.520.77-0.220.95-0.340.950.440.420.680.63
-0.28-0.25-0.62-0.340.420.75-0.35-0.4-0.22-0.250.11-0.24-0.08-0.32-0.61-0.57
0.991.00.840.76-0.7-0.670.740.840.95-0.25-0.051.00.240.640.680.62
-0.02-0.04-0.30.35-0.130.110.570.08-0.340.11-0.05-0.05-0.70.59-0.19-0.17
0.991.00.830.75-0.7-0.640.740.820.95-0.241.0-0.050.240.620.650.59
0.230.230.32-0.330.16-0.14-0.260.190.44-0.080.24-0.70.24-0.230.230.29
0.690.650.550.82-0.51-0.660.920.840.42-0.320.640.590.62-0.230.630.63
0.730.680.910.71-0.51-0.950.580.880.68-0.610.68-0.190.650.230.630.97
0.680.630.860.66-0.31-0.930.520.880.63-0.570.62-0.170.590.290.630.97
Click cells to compare fundamentals

About Vor Biopharma Financial Statements

Vor Biopharma shareholders use historical fundamental indicators, such as Operating Income, to determine how well the company is positioned to perform in the future. Although Vor Biopharma investors may analyze each financial statement separately, they are all interrelated. The changes in Vor Biopharma's assets and liabilities, for example, are also reflected in the revenues and expenses on on Vor Biopharma's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Operating Income-121.2 M-115.1 M
Non Operating Income Net Other1.5 M793.6 K

Additional Tools for Vor Stock Analysis

When running Vor Biopharma's price analysis, check to measure Vor Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vor Biopharma is operating at the current time. Most of Vor Biopharma's value examination focuses on studying past and present price action to predict the probability of Vor Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vor Biopharma's price. Additionally, you may evaluate how the addition of Vor Biopharma to your portfolios can decrease your overall portfolio volatility.